Sito Epatite C
Sito Epatite B
Sito Steatosi
Sito Cirrosi
Portale Epatite e malattie del fegato
Sito Tumori
Sito Trapianti
Nuovi Farmaci
Malattie autoimmuni

Documentazione scientifica

Sherman M. Surveillance for hepatocellular carcinoma and early diagnosis. Clin Liver Dis. 2007 Nov;11(4):817-37

Sangro B. [Diagnosis of small hepatocellular carcinoma] Gastroenterol Hepatol. 2007 Oct;30(8):498-505.

Schacherer D, Schoelmerich J, Zuber-Jerger I. [The diagnostic approach to hepatocellular carcinoma] Z Gastroenterol. 2007 Oct;45(10):1067-74.
 
De Giorgio M, Fagiuoli S. Management of hepatocellular carcinoma. Dig Dis. 2007;25(3):279-81. Review.

Evert M, Dombrowski F. [Hepatocellular carcinoma in the non-cirrhotic liver.] Pathologe. 2008 Feb;29(1):47-52.

Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005 Nov;42(5):1208-36.

Dreyer C, Le Tourneau C, Faivre S, Qian Z, Degos F, Vuillerme MP, Paradis V, Hammel P, Ruszniewski P, Cortes A, Farges O, Belghiti J, Valla D, Raymond E. Cholangiocarcinoma: Epidemiology and global management. Rev Med Interne. 2008 Feb 11;

LinksKim TK, Jang HJ, Burns PN, Murphy-Lavallee J, Wilson SR. Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol. 2008 Jan;190(1):58-66.

Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol. 2008 Jan;48(1):163-70. Epub 2007 Oct 30.

Heiken JP. Distinguishing benign from malignant liver tumours. Cancer Imaging. 2007 Oct 1;7 Spec No A:S1-14. Review

Vuoi ricevere aggiornamenti su questo argomento? Iscriviti alla Newsletter!